Effect of a Selective Mas Receptor Agonist in Cerebral Ischemia In Vitro and In Vivo.

Locomotor activity data indicated a trend for greater impairment in AVE0991-treated mice after stroke with total distance travelled and total time mobile both reduced by >50% compared with vehicle-treated mice, although these differences did not reach statistical significance ( Fig 3A and 3B ; n = 11–12).

also in 111,027 other papers